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doi:10.1016/j.ejvs.2011.05.008Abstract Objective: The objective of this study was to systematically review all available
published data about endovascular stenting for patients with extracranial carotid artery aneu-
rysm (ECAA).
Methods: All clinical reports in the English language on endovascular stenting for ECAA from
1995 through 2010 were identified. General clinical information, aetiology and parameter of
carotid artery aneurysm, information regarding devices, indications for endovascular stenting
and in-hospital and follow-up data of each patient were extracted individually.
Results: A total of 113 studies, involving a total of 224 patients, were included. Procedure
success was reported in 92.8% of patients. Postoperative endoleak was reported in 8.1% of
patients. The incidence of stroke was 1.8%. Cranial nerve injury occurred in 0.5%. Overall
in-hospital mortality was 4.1%. The mean follow-up was 15.4  15.3 months. Stent-graft
patency rate was 93.2%.
Conclusion: Endovascular stenting is technically feasible with high procedure success and rela-
tively low complication rate in patients with ECAA. Both short- and mid-term outcomes appear
to be favourable.
ª 2011 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.Extracranial carotid artery aneurysm (ECAA) is extremely
rare, accounting for only 0.4e4% of all peripheral artery
aneurysms.13 Open surgery, aneurysm resection witheducation questions on this
ation.com and click on ‘CME’
87755766x8198; fax: þ86 20
p.sohu.com (S. Wang).
lsevier Ltd on behalf of Europeaneither interposition grafting or patch angioplasty is
generally accepted as the treatment of choice to prevent
thrombo-embolism-induced neurological dysfunction and
aneurysm rupture. Compared with direct ECAA ligation,
which has a stroke risk of 25% and a mortality of 20%,4
aneurysm resection with carotid artery reconstruction has
achieved significant improvement. However, the open
surgery still carries a relatively high morbidity and
mortality. Mortality and major stroke rate of 9% forSociety for Vascular Surgery.
420 Z. Li et al.surgical reconstruction was reported in one of the largest
series.1
Recent experience suggests that endovascular stenting is
an emerging alternative treatment with promising results
and a revolution from operative to endovascular interven-
tion for ECAA was observed at large centre.5 Due to paucity
of data and lack of large series, limited knowledge of its
safety and efficacy is available. The present study aimed to
summarise all available data concerning clinical success,
complications and outcomes of endovascular stenting for
patients with ECAA.Materials and MethodsData sources
With the search terms ‘carotid artery aneurysm’ OR ‘carotid
artery pseudoaneurysm’ AND ‘stent’ OR ‘endovascular’,
a comprehensive search of the English language medical
literature between January 1995 and December 2010 was
performed using the PubMed database to identify all clinical
reports on endovascular stenting for patients with ECAA. A
multistage assessment was used to include the qualified
reports (Fig. 1). In brief, only the reports with patients
treated by endovascular stenting for ECAAwere included for
further assessment, based on titles and abstracts. The full
articles were reviewed subsequently; only the ones with
sufficient overall data (60% of predefined variables) and
follow-up data for each survival case were included. In the
case of multiple reports of previously listed patients from
a single centre, only the articles with the most recent
number of patients or with most information were included.Definitions
ECAA is subdivided into true and false ECAA (pseudoaneur-
ysm). Procedure success is defined as successful deployment
of stent graft in the target segment of carotid artery to
completely seal the aneurysm without causing fatal compli-
cations, with absence of a type I or III endoleak at the end of
the procedure. Persistent endoleak was defined as an endo-
leak that still existed at the latest follow-up.Figure 1 PRISMA flow diagram.Data extraction
A protocol for data extraction including 45 predefined
variables regarding clinical characteristics, procedural data
and in-hospital and follow-up data was used to analyse each
report in this study. Data were extracted independently by
the first and the second author. Mutual consensus was
achieved by further discussion, when discrepancies
occurred. Unspecified information was classified as not
available; thus, the number of patients (denominator)
varied with the specific variables.Statistical analysis
The number of events divided by the number of treated
patients with available data was used to calculate the
individual rates of events. Results were presented as
percentage (categorical variables) or mean  1 standard
deviation (continuous variables). Comparisons between
subgroups were made using the two-sided c2 test for
categorical variables and two-sided Student’s t-test for
continuous variables. A P-value <0.05 was accepted as
statistical significance. PASW (Predictive Analytics Soft-
ware) Statistics 18.0 was used for all the statistical analysis.ResultsStudies overview
A total of 113 reports, involving 224 patients in all, were
included in this study. General information regarding these
studies was overviewed (Table 1). With an incidence of
43.9%, central neurologic dysfunction was the most
common clinical presentation, followed by pulsatile neck
mass. The patients with true aneurysms were older than
those with pseudoaneurysms, whereas the other variables
were similar between the two subgroups.Data of aneurysms
Nearly half (50.9%) of the ECAA were attributable to
trauma, which was the leading aetiology in all the included
cases. Carotid endarterectomy (CEA) and surgery and/or
radiation for neck cancer, as the second most common
aetiology, were responsible for 11.2% of the aneurysms.
Iatrogenic injury was not uncommon and caused 4.9% of the
aneurysms. Atherosclerosis as aetiology was more common
in the subgroup of true aneurysms compared with the
subgroup of pseudoaneurysms, whereas the other variables
were not different.
The average diameter of the maximal diameter of the
aneurysm was 26.3  17.8 mm. There were 18.4% of
aneurysms with thrombosis in the aneurysmal sac. Carotid
artery stenosis near the aneurysm was observed in 24.7% of
194 aneurysms for which data were available. The internal
carotid artery was the most common site where aneurysm
located, with 37.9% and 35.8% in the right and left internal
carotid arteries, respectively (Table 2).
Table 1 Overview of included reports and patients’ general information.
Variables Aneurysms True aneurysms Pseudoaneurysms
Reports included (n) 113 13 105
Number of patients (n) 224 13 211
Number of aneurysms (n) 258 18 240
Male gender (%) 71.0 (154/217) 83.3 (10/12) 70.2 (144/205)
Age (years) 45.6  19.7 (/209) 56.0  14.1 (/13) 44.9  19.9 (/196)a
Central neurologic dysfunction (%) 43.9 (76/173) 33.3 (3/9) 44.5 (73/164)
Pulsatile neck mass (%) 19.8 (32/162) 22.2 (2/9) 19.6 (30/153)
Compressive symptom (%) 15.3 (25/163) 0 (0/8) 16.1 (25/155)
Coronary heart disease (%) 2.5 (4/159) 0 (0/8) 2.7 (4/151)
a P < 0.05 vs. true aneurysms.
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As many as 265 stents were used in 224 patients, with
a mean of 1.2  0.5 stents per patient. The mean diameter
and length of stent for all aneurysms was 6.6  1.8 mm and
33.9  16.8 mm, respectively. Both mean diameter and
length of stent were greater in the true aneurysms
compared with the pseudoaneurysms. A distal protection
device was applied in 2.3% of patients. Covered stents were
used in 68.4% of patients, whereas bare stents were used in
31.6% of patients. Among all the 22 brands of stent grafts,
Wallstent was the most commonly used, accounting for
27.5% of the 211 patients for whom data were available
(Table 3).Table 2 Data of the aneurysms.
Variables Aneurysms
Etiologies
Trauma (%) 50.9 (1
Carotid endarterectomy (%) 11.2 (2
Surgery and/or radiation for neck cancer (%) 11.2 (2
Dissection (%) 6.7 (1
Iatrogenic injury (%) 4.9 (1
Atherosclerosis (%) 4.5 (1
Behcet disease (%) 2.7 (6
Infection (%) 2.2 (5
Ehlers-Danlos syndrome (%) 0.4 (1
Cryptogenic (%) 4.0 (9
Not available (%) 1.8 (4
Maximal diameter (mm) 26.3  17.8 (
Thrombosis in the aneurysmal sac (%) 18.4 (2
Carotid artery stenosis near aneurysm (%) 24.7 (4
Location
Left carotid bifurcation (%) 1.8 (4
Right carotid bifurcation (%) 1.4 (3
RCCA (%) 12.8 (2
RICA (%) 37.9 (7
RECA (%) 1.4 (3
LCCA (%) 16.0 (3
LICA (%) 35.8 (7
LECA (%) 2.3 (5
a P < 0.05 vs. true aneurysms. RCCA, right common carotid artery;
artery; LCCA, left common carotid artery; LICA, left internal carotidProcedural and in-hospital data
Concerning indications for endovascular stenting rather
than open surgery, 40 cases (17.9%) were treated endo-
vascularly because of high position of the aneurysm and 21
cases because of hostile neck due to previous neck surgery
and/or radiation.
Among 90 patients for whom data were available, 54
patients (60.0%) received intervention under local anaes-
thesia, which was used more in the patients with true
aneurysms compared with those with pseudoaneurysms.
Procedure success of 92.8% was achieved. Postoperative
endoleak occurred in 8.1% of cases and was the leading in-
hospital complication. The incidence of stroke was 1.8%.True aneurysms Pseudoaneurysms
14/224) 0 (0/13) 54.0 (114/211)
5/224) 7.7 (1/13) 11.4 (24/211)
5/224) 7.7 (1/13) 11.4 (24/211)
5/224) 0 (0/13) 7.1 (15/211)
1/224) 0 (0/13) 5.2 (11/211)
0/224) 61.5 (8/13) 1.0 (2/211)a
/224) 7.7 (1/13) 2.4 (5/211)
/224) 0 (0/13) 2.4 (5/211)
/224) 0 (0/13) 0.5 (1/211)
/224) 15.4 (2/13) 3.3 (7/211)a
/224) 7.7 (1/13) 1.4 (3/211)
/75) 31.3  8.9 (/4) 26.1  2.1 (/74)
6/141) 42.9 (3/7) 17.2 (23/134)
8/194) 9.1 (1/11) 25.7 (47/183)
/219) 0 (0/13) 1.9 (4/206)
/219) 0 (0/219) 1.5 (3/206)
8/218) 15.4 (2/13) 12.7 (26/205)
7/203) 30.8 (4/13) 38.4(73/190)
/222) 0 (0/13) 1.4 (3/209)
5/219) 23.1(3/13) 15.5 (32/206)
3/204) 46.2 (6/13) 35.1 (67/191)
/219) 0 (0/13) 1.9 (4/206)
RICA, right internal carotid artery; RECA, right external carotid
artery; LECA, left external carotid artery.
Table 3 Data of devices.
Variables Aneurysms True aneurysms Pseudoaneurysms
Number of stent (n) 1.2  0.5 (265/224) 1.0  0.1 (13/13) 1.2  0.03 (252/211)
Diameter of stent (mm) 6.6  1.8 (/147) 8.0  0.6 (/9) 6.5  0.2 (/138)a
Length of stent (mm) 33.9  16.8 (/156) 55.7  5.3 (/10) 32.4  1.4 (/146)a
Application of distal protection device (%) 2.3 (5/221) 0 (0/13) 2.4 (5/208)
Covered stent (%) 68.4 (80/117) 83.3 (5/6) 67.6 (75/111)
Bare stent (%) 31.6 (37/117) 16.7 (1/6) 32.4 (36/111)
Brands of stents
Wallstent (%) 27.5 (58/211) 7.7 (1/13) 28.8 (57/198)
Wallgraft (%) 15.6 (33/211) 23.1 (3/13) 15.2 (30/198)
Jostent (%) 11.8 (25/211) 30.8 (4/13) 10.6 (21/198)
Smart (%) 9.5 (20/211) 7.7 (1/13) 9.6 (19/198)
Viabahn (%) 10.9 (23/211) 23.1 (3/13) 10.1 (20/198)
Precise (%) 7.6 (16/211) 0 (0/13) 8.1 (16/198)
Palmaz (%) 6.6 (14/211) 0 (0/13) 7.1 (14/198)
Fluency (%) 6.2 (13/211) 7.7 (1/13) 6.1 (12/198)
Vein-covered Palmaz (%) 4.3 (9/211) 0 (0/13) 4.5 (9/198)
Neuroform (%) 2.8 (6/211) 0 (0/13) 3.0 (6/198)
Symbiot (%) 1.9 (4/211) 0 (0/13) 2.0 (4/198)
Acculink (%) 1.3 (3/224) 0 (0/13) 1.4 (3/211)
Hemobahn (%) 0.9 (2/224) 0 (0/13) 1.0 (2/211)
AVE (%) 0.9 (2/211) 0 (0/13) 1.0 (2/198)
NIR (%) 0.9 (2/211) 0 (0/13) 1.0 (2/198)
Passager (%) 0.9 (2/211) 0 (0/13) 1.0 (2/198)
Bx Velocity (%) 0.5 (1/211) 0 (0/13) 0.5 (1/198)
iCast (%) 0.5 (1/211) 0 (0/13) 0.5 (1/198)
Corvita (%) 0.4 (1/224) 0 (0/13) 0.5 (1/211)
Cordis (%) 0.4 (1/224) 0 (0/13) 0.5 (1/211)
Craggstent (%) 0.4 (1/224) 0 (0/13) 0.5 (1/211)
Strecker (%) 0.4 (1/224) 0 (0/13) 0.5 (1/211)
Unknown (%) 6.6 (14/211) 0 (0/13) 7.1 (14/198)
Not available (%) 5.8 (13/224) 0 (0/13) 6.2 (13/211)
a P < 0.05 vs. true aneurysms.
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patients, and in 7.7% of patients with true aneurysms,
higher than the incidence in patients with pseudoaneur-
ysms. Cranial nerve injury caused by the haemorrhage was
observed in one patient (0.5%) who survived neurologically
intact. Anticoagulation was given in 94.4% of patients, with
anti-platelet as the most common regiment. The overall in-
hospital mortality was 4.1% (Table 4); however, none of the
nine deaths was procedure related.
Follow-up data
Follow-up data were available for 218 cases, with a mean
follow-up period of 15.4  15.3 months. Five late deaths
(2.4%), all non-procedure-related, occurred during the
follow-up period. Late surgical conversion and reinterven-
tion were required in 2.4% and 4.7% of patients, respec-
tively. Stent-graft patency was achieved in 93.2% of
patients, with thrombosis of the aneurysmal sac observed in
93.0% of cases. The rate of late complications was 11.7%,
with occlusion (6.3%) as the most common one. Stent-graft
migration, late stroke, rupture of the carotid artery and
stent-graft stenosis were found in two different patients(1.0%), respectively. Stent-graft fracture, intracranial
infection and persistent endoleak were reported in one
patient each (0.5%), respectively (Table 5). Compared with
patients with pseudoaneurysms, patients with true aneu-
rysms had higher rates of overall late complications, stent-
graft migration and late stroke.
Subgroup analysis of covered stents and bare metal
stents
All patients were subcategorised into cases treated by
covered stents and bare metal stents. All variables listed in
aforementioned tables were compared between the two
subgroups, with the most important and/or significantly
different variables listed in Table 6. With respect to baseline
characteristics, patients treated by covered stents were
older, had higher rates of central neurologic dysfunction and
pulsatile neck mass, but lower rates of trauma as aetiology
and high position as endovascular indication, when
compared with patients treated by bare metal stents.
Regarding the outcomes, procedure success rate was similar
in both subgroups, whereas the patients treated with
covered stents presented a slight decrease in postoperative
Table 4 Procedural and in-hospital data.
Variables Aneurysms True aneurysms Pseudoaneurysms
Indications for endovascular stenting
High position of the aneurysm (%) 17.9 (40/224) 15.4 (2/13) 18.0 (38/211)
Hostile neck due to previous neck surgery
and/or radiation (%)
9.4 (21/224) 15.4 (2/13) 9.0 (19/211)
Poor health condition (%) 3.1 (7/224) 0 (0/13) 3.3 (7/211)
Neck infection/inflammation (%) 2.7 (6/224) 0 (0/13) 2.8 (6/211)
None/Not available (%) 68.7 (154/224) 69.2 (9/13) 68.7 (145/211)
Local anesthesia (%) 60.0 (54/90) 100.0 (7/7) 56.6 (47/83)a
Procedure success (%) 92.8 (207/223) 100.0 (12/12) 92.4 (195/211)
Postoperative endoleak (%) 8.1 (18/222) 0 (0/13) 8.6 (18/209)
Stroke (%) 1.8 (4/220) 0 (0/13) 1.9 (4/207)
Need for emergent surgical conversion (%) 0.4 (1/224) 7.7 (1/13) 0.0 (0/211)a
Cranial nerve injury (%) 0.5 (1/222) 0 (0/13) 0.5 (1/209)
Anticoagulation (%) 94.4 (167/177) 100.0 (9/9) 94.1 (158/168)
Anti-platelet (%) 78.5 (139/177) 66.7 (6/9) 79.2 (133/168)
Coumadin (%) 2.3 (4/177) 0 (0/9) 2.4 (4/168)
Heparin (%) 0.6 (1/177) 0 (0/9) 0.6 (1/168)
Combination (%) 12.4 (22/177) 22.2 (2/9) 11.9 (20/168)
Overall in-hospital mortality (%) 4.1 (9/221) 0 (0/13) 4.3 (9/208)
a P < 0.05 vs. true aneurysms.
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tion, overall late complications and stent-graft stenosis and
a significant increase in thrombosis of the aneurysmal sac.
Discussion
ECAA is intriguing due to uncommon occurrence, multiple
aetiologies and poor prognosis if left untreated and still
represents a therapeutic challenge currently.
The condition usually does not provoke attention until
symptoms develop. The most common presentation is
central neurologic dysfunction, either a stroke or a tran-
sient ischaemic attack. Our study demonstrated an inci-
dence of 43.9% of central neurologic dysfunction as theTable 5 Follow-up data.
Variables Aneurysms
Duration of follow-up (months) 15.4  15.3 (/21
Late mortality during follow-up (%) 2.4 (5/20
Need for late surgical conversion (%) 2.4 (5/20
Reintervention (%) 4.7 (10/2
Stent-graft patency (%) 93.2 (193/
Thrombosis of the aneurysmal sac (%) 93.0 (185/
Late complications (%) 11.7 (24/2
Occlusion (%) 6.3 (13/2
Stent-graft migration (%) 1.0 (2/20
Late stroke (%) 1.0 (2/20
Rupture of the carotid artery (%) 1.0 (2/20
Stent-graft stenosis (%) 1.0 (2/20
Stent-graft fracture (%) 0.5 (1/20
Intracranial infection (%) 0.5 (1/20
Persistent endoleak (%) 0.5 (1/20
a P < 0.05 vs. true aneurysms.most common symptom, which is comparable to the
42.0e50.9% of neurologic accidence reported in operative
series.6,7 These events are typically due to embolisation of
thrombus from the aneurysm, supported by the fact that
thrombosis in the aneurysmal sac was found in 18.4% of the
aneurysms. Thus, a possible diagnosis of ECAA should be
suspected when a stroke or a transient ischaemic attack
occurs.
In large series of ECAA treated by open surgery,
atherosclerosis is often cited as the most common cause of
true aneurysm, which accounts for 36.8e42.0% of
patients,6,8 whereas 26.3e56.9% of the aneurysms were
reported as pseudoaneurysms following CEA.1,6 However,
the most common aetiology in the present study wasTrue aneurysms Pseudoaneurysms
8) 20  4.3 (/13) 15.1  1.1 (/205)
5) 0 (0/13) 2.6 (5/192)
6) 7.7 (1/13) 2.1 (4/193)
13) 0.0 (0/12) 5.0 (10/201)
207) 84.6 (11/13) 93.8 (182/194)
199) 100.0 (12/12) 92.5 (173/187)
06) 30.8 (4/13) 10.4 (20/193)a
07) 15.4 (2/13) 5.7 (11/194)
6) 7.7 (1/13) 0.5 (1/193)a
6) 7.7 (1/13) 0.5 (1/193)a
6) 0.0 (0/13) 1.0 (2/193)
6) 0.0 (0/13) 1.0 (2/193)
6) 0.0 (0/13) 1.0 (2/193)
6) 0.0 (0/13) 0.5 (1/193)
6) 0.0 (0/13) 0.5 (1/193)
Table 6 Characteristics and clinical outcomes of patients treated by covered stents vs. bare metal stents.
Variables Covered stents Bare metal stents P-value
Baseline characteristics
Number of patients (n) 80 37 e
Male gender (%) 76.3 (61/80) 66.7 (22/33) 0.29
Age (years) 49.1  2.3 (/80) 39.1  3.6 (/35) 0.021
Central neurologic dysfunction (%) 75.0 (24/32) 31.0 (22/71) <0.0001
Coronary heart disease (%) 2.9 (2/69) 0.0 (0/22) 0.42
Poor health condition (%) 5.0 (4/80) 5.4 (2/37) 0.92
Pulsatile neck mass (%) 30.6 (22/72) 9.1 (2/22) 0.043
Etiology -trauma (%) 43.8 (35/80) 70.3 (26/37) 0.0076
Location- RICA (%) 31.3 (25/80) 71.4 (25/35) 0.0005
Location- LCCA (%) 21.3 (17/80) 2.7 (1/37) 0.0097
Intervention under local anesthesia (%) 47.2 (17/36) 81.8 (9/11) 0.043
Application of distal protection device (%) 2.5 (2/80) 2.9 (1/35) 0.91
Endovascular indication-high position (%) 15.0 (12/80) 37.8 (14/37) 0.0057
Outcomes
Procedure success (%) 91.1 (72/79) 83.8 (31/37) 0.24
Need for emergent surgical conversion (%) 1.3 (1/80) 0.0 (0/37) 0.49
Postoperative endoleak (%) 7.5 (6/80) 18.9 (7/37) 0.068
Stroke (%) 2.5 (2/80) 0.0 (0/37) 0.33
Overall in-hospital mortality (%) 5.0 (4/80) 5.6 (2/36) 0.90
Duration of follow-up (months) 12.4  1.5 (/79) 15.9  2.2 (/35) 0.20
Late mortality during follow-up (%) 1.4 (1/71) 2.9 (1/34) 0.59
Need for late surgical conversion (%) 1.4 (1/72) 2.9 (1/34) 0.58
Reintervention (%) 0.0 (0/79) 22.9 (8/35) <0.0001
Stent-graft patency (%) 91.8 (67/73) 97.1 (33/34) 0.30
Thrombosis of the aneurysmal sac (%) 95.8 (69/72) 70.6 (24/34) 0.0002
Late complications (%) 8.3 (6/72) 23.5 (8/34) 0.031
Occlusion (%) 8.2 (6/73) 0.0 (0/34) 0.085
Stent-graft migration (%) 0.0 (0/72) 2.9 (1/34) 0.14
Late stroke (%) 1.4 (1/72) 2.9 (1/34) 0.58
Rupture of the carotid artery (%) 0.0 (1/72) 2.9 (1/34) 0.14
Stent-graft stenosis (%) 0.0 (0/72) 5.9 (2/34) 0.038
Stent-graft fracture (%) 1.4 (1/72) 0.0 (0/34) 0.49
Persistent endoleak (%) 0.0 (0/72) 2.9 (1/34) 0.14
424 Z. Li et al.trauma, which accounted for 50.9% of patients, whereas
CEA and atherosclerosis only accounted for 11.2% and 4.5%
of patients, respectively. This different proportion of
aetiology may reflect the increasing availability and pref-
erence of endovascular stenting for emergent patients who
might be complicated with multiple trauma or even
unstable circulation.
Cooper documented the first successful procedure,
a proximal ligation, for ECAA in 1808.9 During the following
150 years, ligation remained the mainstay of treatment.
However, the prognosis was not satisfactory, with a risk of
stroke and mortality up to 25% and 20%, respectively.4 Since
the first successful resection of aneurysm combined with
reconstruction of the involved artery was performed in
1956, reconstruction of the carotid arterial system has
become the gold standard.10,11 The clinical outcome has
gained significant improvement, achieving a reduced post-
operative mortality and neurologic incidence of 2.2e6.0%
and 5.5e10%, respectively.1,6,12 However, the open repair is
criticised for its high co-morbidity of cranial nerve deficit,
occurring in 2.2e44%.12,13 Further, surgical repair istechnically difficult when the aneurysms are located near
the skull base, requiring a very extensive and invasive
exposure of the lesions.13 The open access is also chal-
lenging in patients with hostile neck due to previous neck
surgery and/or radiation. All these factors may partially
explain the increasing popularity of endovascular stenting
for ECAA, after its successful application in many other
areas. When compared with surgery, endovascular stenting
reduces the need of general anaesthesia and allows
continuous monitoring of the neurological status intra-
interventionally. Patients can therefore avoid the potential
devastating neurologic complications and also enjoy a more
rapid recuperation. This systematic review showed that
procedure success of 92.8% was achieved. The rates of
overall in-hospital mortality, stroke and cranial nerve injury
were 4.1%, 1.8% and 0.5%, respectively. In general, endo-
vascular stenting has achieved a comparable, if not better,
clinical outcome in patients with ECAA.
Furthermore, an attempt was made to compare the
outcomes of the true and false ECAA treated by endovas-
cular stenting, considering the absence of such evaluation
Stenting of Extracranial Carotid Artery Aneurysm 425and the expected heterogeneity between these two
subgroups. It is not surprising that the patients with true
aneurysms were older and had atherosclerosis as the most
common aetiology. The greater mean maximal diameter (of
true aneurysms), though not significantly different from
that for the pseudoaneurysms, may partially explain the
greater diameter and length of stents used for the true
aneurysms. It is plausible that elevated rates of overall late
complication, stroke and stent-graft migration may be due
to older age and continuous degenerative vascular diseases.
Thus, potentially different characteristics and outcomes
should be kept in mind when managing the true and false
ECAA, though most of the other variables were comparable.
There is no treatment guideline or expert consensus for
the management of ECAA till today. Based on the data
summarised in this study, high position of the aneurysm is
the major indication for preference of endovascular
stenting, which also is commonly indicated in hostile neck
due to previous neck surgery and/or radiation. Patients
with poor health condition and neck infection, contra-
indicated for traditional surgery, are also believed to
benefit from this intervention. Whereas all aforementioned
indications verify the rationality, endovascular stenting was
preferred in 68.7% of cases without indications or with data
not available, which might represent a revolution from
operative to endovascular intervention for ECAA.
Though endovascular stenting of ECAA has gained
increasing popularity because of less invasiveness and
favourable outcome, it is not free from disadvantages and
complications. The major post-interventional complica-
tions are early thrombosis, late stenosis and occlusion of
stent graft. Therefore, adequate anticoagulation should be
initiated after stent implantation, with particular attention
being paid to monitoring graft patency. Though 94.4% of
patients were on anticoagulation therapy, 6.3% of occlusion
occurred. Numerous stents have been produced to improve
patency rate and durability. It has been argued that
covered stents should only be used if the arterial defect is
large, as in post-CEA pseudoaneurysms, or in the case of
true ECAA, whereas bare stents appear to be appropriate in
pseudoaneurysms in which the arterial defect is small, such
as post-traumatic pseudoaneurysms.14 By contrast, many
advocate covered stents as the choice for traumatic ECAA,
as they provide immediate occlusion of the lesion, redirect
flow through the carotid artery and minimise the risk of
distal embolisation.15,16 Actually, the percentages of
covered stents and bare metal stents used in pseudoa-
neurysms were similar, failing to demonstrate a preference
for either type of stent. Of note, the patients treated with
covered stents enjoyed a slight decrease in postoperative
endoleak, a significant decrease in reintervention, late
complications and stent-graft stenosis and an increase in
thrombosis of the aneurysmal sac, which may support the
covered stent as a better choice for ECAA.
To the best of our knowledge, this study is the first one
to systematically summarise all available data with respect
to endovascular stenting of ECAA, which may serve as the
best evidence so far of evaluating the safety and efficacy of
this therapy strategy, and being compared with the open
surgery. Nevertheless, the limitations of our study should
be pointed out. The study is a selection of patients mainly
from case reports that may suffer from selection andpublication bias. However, the detailed information
provided in case report offers the possibility of extracting
the most individual data and performing more informative
statistical analysis. Of further note, we may risk drawing
a less reliable conclusion, mainly due to the expected
heterogeneity of reports with limited number of cases. We
must keep in mind that this study is limited by the avail-
ability of only data from non-randomised controlled trial
and clinicians should be extremely cautious about using
these data for decision making.
Conclusion
Endovascular stenting is technically feasible with high
procedure success and relatively low complication rate in
patients with ECAA. Both short- and mid-term outcomes
appear to be favourable.
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